The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of 3q Amplification in Head and Neck Cancer.
 
Takeshi Kato
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Takeda
Research Funding - Chugai Pharma
Expert Testimony - Lilly
 
Takayuki Yoshino
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline K.K. (Inst)
 
Takeharu Yamanaka
Honoraria - Boehringer Ingelheim; Chugai Pharma; Taiho Pharmaceutical; Takeda
Research Funding - Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Masahito Kotaka
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Dai Manaka
No Relationships to Disclose
 
Tetsuya Eto
No Relationships to Disclose
 
Junichi Hasegawa
No Relationships to Disclose
 
Akinori Takagane
No Relationships to Disclose
 
Masato Nakamura
Honoraria - Chugai Pharma; Lilly; Merck; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer; Merck
 
Yoshinori Munemoto
No Relationships to Disclose
 
Fumitaka Nakamura
No Relationships to Disclose
 
Hiroyuki Bando
No Relationships to Disclose
 
Hiroki Taniguchi
No Relationships to Disclose
 
Makio Gamoh
No Relationships to Disclose
 
Manabu Shiozawa
No Relationships to Disclose
 
Shigetoyo Saji
No Relationships to Disclose
 
Yoshihiko Maehara
Speakers' Bureau - Chugai Pharma; Yakult Pharmaceutical
Research Funding - Chugai Pharma; Kyowa Hakko Kirin; Yakult Pharmaceutical
 
Tsunekazu Mizushima
No Relationships to Disclose
 
Atsushi Ohtsu
Employment - Celgene (I)
Research Funding - Bristol-Myers Squibb
 
Masaki Mori
No Relationships to Disclose